AO CSH Mainstream Study on Cervical Spine Degeneration
CASDEM
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Adult patients with cervical degenerative diseases undergoing primary anterior and/or posterior cervical fusion will be prospectively enrolled from participating sites. Patients will be treated and followed up at the participating sites per local standard of care. Several variables related to the patient characteristics and fusion details will be collected. The mainstream study will not collect follow-up (FU) data. The duration of this patient cohort is currently planned as open ended.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2035
February 25, 2025
February 1, 2025
5.1 years
February 19, 2025
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Form a large patient cohort
The primary objective is to form a large prospective multicenter patient cohort with standardized data collection of key patient and treatment characteristics that will drive hypothesis generation in patients with cervical degenerative diseases.
Baseline
Eligibility Criteria
Adult patients with cervical degenerative diseases undergoing primary anterior and/or posterior cervical fusion will be prospectively enrolled from participating sites.
You may qualify if:
- Age 18 years and older
- Undergoing primary surgical treatment for cervical degenerative disease
- Ability to provide informed consent according to the IRB/EC defined and approved procedures
You may not qualify if:
- Age under 18 years
- Patients with spinal infection
- Patients with spinal tumor
- Patients with acute spinal injuries/trauma within 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2025
First Posted
February 25, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
July 31, 2030
Study Completion (Estimated)
July 31, 2035
Last Updated
February 25, 2025
Record last verified: 2025-02